Surmodics | SRDX - Stock


Surmodics reported $15.17M in Stock for its fiscal quarter ending in September of 2024.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Align Technology USD 214.94M 11.4M Mar/2026
Anika Therapeutics USD 22.84M 4.05M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Artivion USD 97.99M 5.57M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Boston Scientific USD 3.12B 174M Mar/2026
EDAP TMS EUR 13.8M 1.73M Sep/2025
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
Haemonetics USD 306.37M 14.82M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
J&J USD 14.58B 392M Mar/2026
Merit Medical Systems USD 352.39M 18.68M Mar/2026
Mesa Laboratories USD 26.56M 1.18M Dec/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Option Care Health USD 415.69M 55.46M Mar/2026
Stryker USD 5.42B 109M Mar/2026
Surmodics USD 15.17M 230K Sep/2024
Trinity Biotech USD 19.16M 210K Sep/2025